CN1086141C - Medicine for treating early-stage hepatocirrhosis and its preparation - Google Patents

Medicine for treating early-stage hepatocirrhosis and its preparation Download PDF

Info

Publication number
CN1086141C
CN1086141C CN99122355A CN99122355A CN1086141C CN 1086141 C CN1086141 C CN 1086141C CN 99122355 A CN99122355 A CN 99122355A CN 99122355 A CN99122355 A CN 99122355A CN 1086141 C CN1086141 C CN 1086141C
Authority
CN
China
Prior art keywords
medicine
preparation
radix
hepatocirrhosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99122355A
Other languages
Chinese (zh)
Other versions
CN1284376A (en
Inventor
郝忠礼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99122355A priority Critical patent/CN1086141C/en
Publication of CN1284376A publication Critical patent/CN1284376A/en
Application granted granted Critical
Publication of CN1086141C publication Critical patent/CN1086141C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a series traditional Chinese medicine classification preparation (IV) for curing the livers, which is especially used for curing virus hepatitis. The preparation (IV) is special medicine for curing early hepatic cirrhosis, has strong pertinence to the cure of early hepatic cirrhosis, and simultaneously, has the advantages of high curative effect, quick curative effect, etc.

Description

A kind of treatment early stage liver cirrhosis medicine and preparation method thereof
The present invention is dividing an application of former " classification liver treating agent and preparation method thereof ", and original application day 970604, original applying number 97105120.8 the present invention relates to a kind of serial Chinese medicine for the treatment of viral hepatitis.
At present, viral hepatitis is a kind of common frdquently encountered disease of serious harm human life health, according to the interrelated data introduction, China is the higher country of hepatopathy sickness rate, China's HBSAG carrier people more than 100,000,000, and the trend that increases is year by year arranged, die from hepatocarcinoma, about 300,000 people of liver cirrhosis person every year.Usually run into following thorny problem to viral hepatitis treatment now both at home and abroad, and Western medicine class curative effect is low, and side effect is big, cost an arm and a leg, with the western medicine viral hepatitis can only improve immunity and the course of treatment long, can not very fast removing hepatitis virus.The Chinese patent medicine that is used for the treatment of viral hepatitis also has much, but kind is single, and a kind of medicine is difficult to the multiple symptom in each stage of treatment all kinds and every type, that is to say to execute to the ill categorizedly and control that therapeutic effect is also not obvious.
The objective of the invention is to propose a kind of removing hepatovirus that has, the reparation of soothing the liver, easing the affected liver, tonifying liver, acceleration liver organization strengthens human immunity, reduces a kind of treatment early stage liver cirrhosis medicine of hepatopathy complication and preparation method thereof.
Solution of the present invention is based on motherland's Chinese medicine to hepatopathy and pathogenetic understanding of complication and Therapeutic Principle, with reference to modern medicine pharmacological research achievement, from the Chinese medicine treasure-house of motherland, filter out and can remove hepatovirus, change congestion, regulate the flow of vital energy, soothing the liver, easing the affected liver, tonifying liver, spleen invigorating, the natural animal and plant of the body resistance strengthening and constitution consolidating, mineral be raw material, by the theory of Chinese medical science prescription.
The present invention be specifically designed to the treatment early stage liver cirrhosis medicine be to make by the raw material of following weight portion:
Radix Isatidis 15-25 part Herba Taraxaci 10-20 part Flos Lonicerae 15-25 part
Fructus Forsythiae 10-20 part Radix Scrophulariae 15-25 part Herba Artemisiae Scopariae 10-20 part
Poria 10-20 part Rhizoma Atractylodis Macrocephalae 10-20 part Carapax et Plastrum Testudinis 10-20 part
Carapax Trionycis 10-20 part rhizoma sparganic 5-15 part Rhizoma Curcumae 5-15 part
Fructus Toosendan 10-20 part Radix Paeoniae Alba 15-25 part Flos Campsis 5-15 part
Radix Paeoniae Rubra 10-20 part Natrii Sulfas 0.5-5 part Alumen 0.5-5 part
Rhizoma Curcumae Longae 5-15 part Radix Glycyrrhizae 10-20 part Rhizoma Corydalis 10-20 part
When the special-purpose medicine of above-mentioned treatment early stage liver cirrhosis is prepared, through after selecting materials, cleaning, earlier that Radix Isatidis, Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae, Radix Scrophulariae, Herba Artemisiae Scopariae, Poria, the Rhizoma Atractylodis Macrocephalae, Carapax et Plastrum Testudinis, Carapax Trionycis, rhizoma sparganic, Rhizoma Curcumae, Fructus Toosendan, the Radix Paeoniae Alba, Flos Campsis, Radix Paeoniae Rubra, Rhizoma Curcumae Longae, Radix Glycyrrhizae is air-dry, pulverize, be screened to 100 orders, again 100 orders are pulverized, are screened to Natrii Sulfas, Alumen, in addition 100 orders are fried, pulverized, are screened to Rhizoma Corydalis vinegar, at last above-mentioned 21 flavor medicated powder are stirred packing.
Advantages such as the present invention has stronger specific aim to the treatment early stage liver cirrhosis, has the curative effect height simultaneously, and curative effect is fast.
Embodiment: during this medicine (the special-purpose medicine of treatment early stage liver cirrhosis) preparation, through after selecting materials, cleaning, earlier that Radix Isatidis, Herba Taraxaci, Flos Lonicerae, Fructus Forsythiae, Radix Scrophulariae, Herba Artemisiae Scopariae, Poria, the Rhizoma Atractylodis Macrocephalae, Carapax et Plastrum Testudinis, Carapax Trionycis, rhizoma sparganic, Rhizoma Curcumae, Fructus Toosendan, the Radix Paeoniae Alba, Flos Campsis, Radix Paeoniae Rubra, Rhizoma Curcumae Longae, Radix Glycyrrhizae is air-dry, pulverize, be screened to 100 orders, again 100 orders are pulverized, are screened to Natrii Sulfas, Alumen, in addition 100 orders are fried, pulverized, are screened to Rhizoma Corydalis vinegar, at last above-mentioned 21 flavor medicated powder are stirred packing.

Claims (1)

1, a kind of early-phase hepatocirrhosis medicine for the treatment of is characterized in that being made by following weight portion: the public English 10-20 of isatis root 15-25 part part honeysuckle 15-25 part capsule of weeping forsythia 10-20 part radix scrophulariae 15-25 part oriental wormwood 10-20 part Poria cocos 10-20 part bighead atractylodes rhizome 10-20 part tortoiseshell 10-20 part turtle shell 10-20 part triangular 5-15 part curcuma zedoary 5-15 part Fructus meliae toosendan 10-20 part root of herbaceous peony 15-25 part Chinese trumpet creeper 5-15 part radix paeoniae rubrathe 10-20 part saltcake 0.5-5 part alum 0.5-5 part turmeric 5-15 part Radix Glycyrrhizae 10-20 part corydalis tuber 10-20 part
CN99122355A 1999-11-03 1999-11-03 Medicine for treating early-stage hepatocirrhosis and its preparation Expired - Fee Related CN1086141C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99122355A CN1086141C (en) 1999-11-03 1999-11-03 Medicine for treating early-stage hepatocirrhosis and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99122355A CN1086141C (en) 1999-11-03 1999-11-03 Medicine for treating early-stage hepatocirrhosis and its preparation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN97105120A Division CN1052913C (en) 1997-06-04 1997-06-04 Classified liver treating agent and it prepn. method

Publications (2)

Publication Number Publication Date
CN1284376A CN1284376A (en) 2001-02-21
CN1086141C true CN1086141C (en) 2002-06-12

Family

ID=5282459

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99122355A Expired - Fee Related CN1086141C (en) 1999-11-03 1999-11-03 Medicine for treating early-stage hepatocirrhosis and its preparation

Country Status (1)

Country Link
CN (1) CN1086141C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1309411C (en) * 2002-12-11 2007-04-11 武汉宜芝林医药技术开发有限公司 Fat-eliminating liver-protecting medicine capsule for treating hepatosis and its prepn
CN100337682C (en) * 2005-04-16 2007-09-19 程育武 Oral liquid for treating virus bepatitis B

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079157A (en) * 1993-03-20 1993-12-08 赵三立 Medicine " Ganyanfukangling " for curing hepatitis
CN1108943A (en) * 1994-03-21 1995-09-27 李春祥 Medicine "Yigankang" for hepatitis B and its preparation
CN1137393A (en) * 1995-06-08 1996-12-11 孟涛 Yisuishengxue Chinese medicine preparation for tonifying marrow and promoting generation of blood
CN1142391A (en) * 1996-07-05 1997-02-12 苏优强 Oral liquid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1079157A (en) * 1993-03-20 1993-12-08 赵三立 Medicine " Ganyanfukangling " for curing hepatitis
CN1108943A (en) * 1994-03-21 1995-09-27 李春祥 Medicine "Yigankang" for hepatitis B and its preparation
CN1137393A (en) * 1995-06-08 1996-12-11 孟涛 Yisuishengxue Chinese medicine preparation for tonifying marrow and promoting generation of blood
CN1142391A (en) * 1996-07-05 1997-02-12 苏优强 Oral liquid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《吉林中医药》1991,(3) 1991.4.1 周有信,"舒肝消积丸" *

Also Published As

Publication number Publication date
CN1284376A (en) 2001-02-21

Similar Documents

Publication Publication Date Title
CN100356972C (en) Chinese medicine for treating amblyopia and myopia
CN100496586C (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN103432503B (en) Traditional Chinese medicine composition
CN110960619A (en) Traditional Chinese medicine composition for treating African swine fever
CN100400094C (en) Traditional Chinese medicine for treating hepatitis B and its preparing process
CN1052413C (en) Yinhuang Ganfu powder for curing hepatitis
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN1218706C (en) Hepatitis B treaitng pill
CN1086141C (en) Medicine for treating early-stage hepatocirrhosis and its preparation
CN101062347A (en) Chinese traditional medicine formula good for heart and brain
CN1052913C (en) Classified liver treating agent and it prepn. method
CN1356124A (en) Medicine for treating hepatism
CN1090183A (en) Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof
CN1240415C (en) Tablets against allergic purpura
CN1086142C (en) Medicine for treating resting-stage hepatitis B and its prepartion
CN1923269A (en) Medicine for treating hepatitis B
CN1086143C (en) Medicine for treating active-stage hepatitis B and its preparation
CN1058622C (en) Rehabilitation powder for hepatitis B
CN1164318C (en) Capsule for treating gynaecological inflammation
CN101229291B (en) Chinese traditional medicine composition for treating virus hepatitis by immunoregulation
CN1053825C (en) Wuling C-hepatitis powder
CN1562327A (en) Decoction of turning negative in five steps for virus of hepatitis B
CN1321474A (en) Yigan Jiedu tea for curing hepatitis B and its preparation method
CN1136896C (en) Live-nourishing 'yanggan' pill
CN1188155C (en) Bear gall pill of benefiting the liver

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee